Serum uric acid and renal transplantation outcomes: At least 3-year post-transplant retrospective multivariate analysis

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Zhang, Kun ^a   Gao, Baoshan ^a   Wang, Yuantao ^a   Wang, Gang ^a   Wang, Weigang ^a   Zhu, Yaxiang ^a   Yao, Liyu ^a   Gu, Yiming ^a   Chen, Mo ^a   Zhou, Honglan ^a   Fu, Yaowen ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; DIURETIC AGENT; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; URIC ACID;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; COMORBIDITY; DONOR; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROGNOSIS; TIME FACTOR;

ADULT; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; URIC ACID;

EID: 84941633463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133834     Document Type: Article

References (47)

1. Levy AR, Briggs AH, Johnston K, MacLean JR, Yuan Y, L'Italien GJ, et al. Projecting long-term graft and patient survival after transplantation. Value in health: The journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014; 17(2):254-60. Epub 2014/03/19. doi:10.1016/j.jval.2014.01.001 PMID: 24636384.
2. Paul LC. Chronic allograft nephropathy: An update. Kidney international. 1999; 56(3):783-93. doi:10.1046/j.1523-1755.1999.00611.x PMID: 10469349.
3. Svensson M, Jardine A, Fellstrom B, Holdaas H. Prevention of cardiovascular disease after renal transplantation. Current opinion in organ transplantation. 2012; 17(4):393-400. Epub 2012/07/14. doi:10.1097/MOT.0b013e3283560a3b PMID: 22790074.
4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108(17):2154-69. Epub 2003/10/29. doi:10.1161/01.CIR.0000095676.90936.80 PMID: 14581387.
5. Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, et al. The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation. 2010; 89(5):573-9. Epub 2009/12/10. doi:10.1097/TP.0b013e3181c73c18PMID: 19997058.
6. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney international. 2005; 67(5):1739-42. Epub 2005/04/21. doi:10.1111/j.1523-1755.2005.00273.x PMID: 15840020.
7. Hong Q, Qi K, Feng Z, Huang Z, Cui S, Wang L, et al. Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload. Cell calcium. 2012; 51(5):402-10. Epub 2012/03/01. doi:10.1016/j.ceca.2012.01.003 PMID: 22361139.
8. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN. Inactivation of nitric oxide by uric acid. Nucleosides, nucleotides & nucleic acids. 2008; 27(8):967-78. Epub.
9. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. The American journal of cardiology. 2005; 96(11):1576-8. Epub 2005/11/29. doi:10.1016/j.amjcard.2005.07.068 PMID: 16310444.
10. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003; 41(6):1287-93. Epub 2003/05/14. doi:10.1161/01.HYP.0000072820.07472.3B PMID: 12743010.
11. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. American journal of nephrology. 2005; 25(5):425-33. Epub 2005/08/23doi:10.1159/000087713PMID: 16113518.
12. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003; 425(6957):516-21. Epub 2003/10/02. doi:10.1038/nature01991 PMID: 14520412.
13. Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Current hypertension reports. 2006; 8(2):111-5. Epub 2006/05/05. PMID: 16672142.
14. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. American journal of physiology Renal physiology. 2002; 282(6):F991-F7. Epub 2002/05/09doi:10.1152/ajprenal.00283.2001 PMID: 11997315.
15. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. Journal of the American Society of Nephrology: JASN. 2005; 16(12):3553-62. Epub 2005/10/28doi:10.1681/ASN.2005050572PMID: 16251237.
16. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. European heart journal. 2006; 27(10):1174-81. Epub 2006/04/14. doi:10.1093/eurheartj/ehi879 PMID: 16611671; PubMed Central PMCID: PMC2668163.
17. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow- up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000; 283 (18):2404-10. Epub 2000/05/18. PMID: 10815083.
18. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 2000; 36(6):1072-8. Epub 2000/01/11. PMID: 11116127.
19. Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. American journal of nephrology. 2005; 25(1):36-44. Epub 2005/02/23. doi:10.1159/000084073 PMID: 15724081.
20. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. The New England journal of medicine. 2008; 359(17):1811-21. Epub 2008/10/24. doi:10.1056/NEJMra0800885 PMID: 18946066; PubMed Central PMCID: PMC2684330.
21. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2009; 24(4):1260-6.Epub 2008/11/27. doi:10.1093/ndt/gfn621 PMID: 19033255; PubMed Central PMCID: PMC2721426.
22. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertension research: official journal of the Japanese Society of Hypertension. 2001; 24(6):691-7. Epub 2002/01/05. PMID: 11768729.
23. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. American journal of kidney diseases: The official journal of the National Kidney Foundation. 2004; 44(4):642-50. Epub 2004/09/24. PMID: 15384015.
24. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. Journal of the American Society of Nephrology: JASN. 2008; 19(6):1204- 11. Epub 2008/03/14. doi:10.1681/ASN.2007101075PMID: 18337481; PubMed Central PMCID: PMC2396939.
25. Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, et al. Elevated uric acid increases the risk for acute kidney injury. The American journal of medicine. 2012; 125(3):302 e9-17. Epub 2012/02/22. doi:10.1016/j.amjmed.2011.06.021 PMID: 22340933.
26. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, et al. Relationship of uric acid with progression of kidney disease. American journal of kidney diseases: The official journal of the National Kidney Foundation. 2007; 50(2):239-47. Epub 2007/07/31. doi:10.1053/j.ajkd.2007.05.013 PMID: 17660025.
27. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A randomized trial. JAMA. 2008; 300(8):924-32. Epub 2008/08/30. doi:10.1001/jama.300.8.924 PMID: 18728266; PubMed Central PMCID: PMC2684336.
28. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. American journal of kidney diseases: The official journal of the National Kidney Foundation. 2006; 47(1):51-9. Epub 2005/12/27. doi:10.1053/j.ajkd.2005.10.006 PMID: 16377385.
29. Barberi S, Mene P. [Role of uric acid in hypertension and in the progression of chronic renal disease]. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia. 2006; 23(1):4-11. Epub 2006/03/08. PMID: 16521070.
30. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney international. 2005; 67(1):237-47. Epub 2004/12/22. doi:10.1111/j.1523-1755.2005.00074.x PMID: 15610247.
31. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. American journal of physiology Renal physiology. 2002; 283(5):F1105-F10. Epub 2002/10/10. doi:10.1152/ajprenal.00170.2002 PMID: 12372787.
32. Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, et al. Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation. 2001; 71(7):900-5. Epub 2001/05/15. PMID: 11349724. 33.
33. Mazali FC, Mazzali M. Uric acid and transplantation. Seminars in nephrology. 2011; 31(5):466-71. Epub 2011/10/18. doi:10.1016/j.semnephrol.2011.08.012 PMID: 22000655.
34. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9):604-12. Epub 2009/05/06. PMID: 19414839; PubMed Central PMCID: PMC2763564.
35. Liu X, Wang Y, Wang C, Shi C, Cheng C, Chen J, et al. A new equation to estimate glomerular filtration rate in Chinese elderly population. PloS one. 2013; 8(11):e79675. Epub 2013/11/19. doi:10.1371/journal.pone.0079675 PMID: 24244543; PubMed Central PMCID: PMC3823564.
36. Ray C, Sohrabi S, Talbot D. Machine perfusion or cold storage in deceased-donor kidney transplantation. The New England journal of medicine. 2009; 360(14):1460; author reply 1. Epub 2009/04/03. doi:10.1056/NEJMc090170 PMID: 19339728.
37. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. Effect of insulin on uric acid excretion in humans. The American journal of physiology. 1995; 268(1 Pt 1):E1-E5. Epub 1995/01/01. PMID: 7840165.
38. Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: Which is chasing which? Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2013; 28(9):2221-8. Epub 2013/04/02. doi:10.1093/ndt/gft029 PMID: 23543594.
39. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease- major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation. 1995; 60(5):451-7. Epub 1995/09/15. PMID: 7676492.
40. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. American journal of kidney diseases: The official journal of the National Kidney Foundation. 1998; 32(5 Suppl 3):S142-56. Epub 1998/11/20. PMID: 9820472.
41. Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, Haberal M. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplantation proceedings. 2007; 39(4):1023-6. Epub 2007/05/26. doi:10.1016/j.transproceed.2007.03.028 PMID: 17524881.
42. Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric acid levels have no significant effect on renal function in adult renal transplant recipients: Evidence from the symphony study.Clinical journal of the American Society of Nephrology: CJASN. 2009; 4(10):1655-60. Epub 2009/08/29doi:10.2215/CJN.02700409PMID: 19713295; PubMed Central PMCID: PMC2758252.
43. Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, et al. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012; 94 (2):145-51. Epub 2012/06/26. doi:10.1097/TP.0b013e318254391b PMID: 22728291.
44. Akalin E, Ganeshan SV, Winston J, Muntner P. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Transplantation. 2008; 86(5):652-8. Epub 2008/09/16doi:10.1097/TP.0b013e3181814f5bPMID: 18791445.
45. Haririan A, Metireddy M, Cangro C, Nogueira JM, Rasetto F, Cooper M, et al. Association of serum uric acid with graft survival after kidney transplantation: A time-varying analysis. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011; 11(9):1943-50. Epub 2011/08/05. doi:10.1111/j.1600-6143.2011.03613.x PMID: 21812917.
46. Huang Y, Li YL, Huang H, Wang L, Yuan WM, Li J. Effects of hyperuricemia on renal function of renal transplant recipients: A systematic review and meta-analysis of cohort studies. PloS one. 2012; 7(6): E39457. Epub 2012/06/30. doi:10.1371/journal.pone.0039457 PMID: 22745759; PubMed Central PMCID: PMC3382160.
47. Gerhardt U, Grosse Huttmann M, Hohage H. Influence of hyperglycemia and hyperuricemia on longterm transplant survival in kidney transplant recipients. Clinical transplantation. 1999; 13(5):375-9. Epub 1999/10/09. PMID: 10515217.